HRP20120874T1 - Pripravci za lijeäśenje poremeä†aja gornjeg dišnog trakta i sindroma influence - Google Patents

Pripravci za lijeäśenje poremeä†aja gornjeg dišnog trakta i sindroma influence Download PDF

Info

Publication number
HRP20120874T1
HRP20120874T1 HRP20120874AT HRP20120874T HRP20120874T1 HR P20120874 T1 HRP20120874 T1 HR P20120874T1 HR P20120874A T HRP20120874A T HR P20120874AT HR P20120874 T HRP20120874 T HR P20120874T HR P20120874 T1 HRP20120874 T1 HR P20120874T1
Authority
HR
Croatia
Prior art keywords
preparations
extract
hippophae rhamnoides
specified
benzophenanthridine alkaloids
Prior art date
Application number
HRP20120874AT
Other languages
English (en)
Inventor
Ezio Bombardelli
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI20081029 external-priority patent/ITMI20081029A1/it
Priority claimed from EP08425420A external-priority patent/EP2133089A1/en
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of HRP20120874T1 publication Critical patent/HRP20120874T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/36Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/473Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)

Claims (10)

1. Pripravci naznačeni time da su zasnovani na sljedećim: a) benzofenantridinni alkoloidi, b) ekstrakt Hippophae rhamnoides, c) lipofilni ekstrakt Echinacea angustifolia.
2. Pripravci kako su navedeni u patentnom zahtjevu 1, naznačeni time da su zasnovani na sljedećim: a) benzofenantridinski alkoloidi odabrani od sljedećih: sanguinarine, helerithrin te kelidonin. b) ekstrakt Hippophae rhamnoides obogaćen derivatima elagične kiseline, c) lipofilni ekstrakt Echinacea angustifolia.
3. Pripravci kako su navedeni u patentnim zahtjevima 1 i 2, naznačeni time da su razne komponente prisutne u sljedećim rasponima (masa po jedinici doze): a) benzofenantridinski alkoloidi: od 1 do 5; b) ekstrakt Hippophae rhamnoides: od 10 do 100; c) lipofilni ekstrakt Echinacea angustifolia: od 0.2 do 2.
4. Pripravci kako su navedeni u prethodnim patentnim zahtjevima, naznačeni time da su benzofenantridinski alkoloidi sangvinarin, helerithrin te kelidonin prisutni u slobodnom obliku ili u obliku soli, u čistom obliku ili u obliku ekstrakata Sanguinaria canadensis, Macleaya cordata ili Macleaya microcarpa ili Chelidonium majus.
5. Pripravci kako su navedeni u patentnom zahtjevu 4, naznačeni time da su benzofenantridinski alkoloidi prisutni u obliku soli lutenske kiseline.
6. Pripravci kako su navedeni u patentnim zahtjevima 1-5, naznačeni time da je ekstrakt Hippophae rhamnoides prisutan kao ekstrakt Hippophae rhamnoides dobiven ekstrakcijom dijelova obogaćenih derivativima elagične kiseline.
7. Pripravci kako su navedeni u patentnom zahtjevu 6, naznačeni time da je ekstrakt Hippophae rhamnoides prisutan kao ekstrakt Hippophae rhamnoides sa sadržajem 90 % elagitinina.
8. Pripravci kako su navedeni u patentnim zahtjevima 1 do 7, naznačeni time da su u obliku tableta koje se polako otapaju u oralnoj šupljini ili guma za žvakanje koje polako oslobađaju aktivne tvari, vode za usta, gelova za disperziju u oralnoj šupljini i slično.
9. Pripravci naznačeni time da su zasnovani na sljedećim: a) benzofenantridinni alkoloidi, b) ekstrakt Hippophae rhamnoides, c) lipofilni ekstrakt Echinacea angustifolia za upotrebu u liječenju bakterijskih i virusnih poremećaja gornjeg respiratornog trakta.
10. Pripravci prema patentnom zahtjevu 9, naznačeni time da bakterijski i virusni poremećaji gornjeg respiratornog trakta potječu od stanja uzrokovanih virusima influence.
HRP20120874AT 2008-06-05 2012-10-30 Pripravci za lijeäśenje poremeä†aja gornjeg dišnog trakta i sindroma influence HRP20120874T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20081029 ITMI20081029A1 (it) 2008-06-05 2008-06-05 Composizioni per il trattamento delle affezioni delle prime vie respiratorie e delle sindromi influenzali
EP08425420A EP2133089A1 (en) 2008-06-12 2008-06-12 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes
PCT/EP2009/003673 WO2009146807A1 (en) 2008-06-05 2009-05-25 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndroms

Publications (1)

Publication Number Publication Date
HRP20120874T1 true HRP20120874T1 (hr) 2012-11-30

Family

ID=40872454

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20120874AT HRP20120874T1 (hr) 2008-06-05 2012-10-30 Pripravci za lijeäśenje poremeä†aja gornjeg dišnog trakta i sindroma influence

Country Status (16)

Country Link
US (1) US9101604B2 (hr)
EP (1) EP2285393B1 (hr)
JP (2) JP5992171B2 (hr)
KR (1) KR20110027671A (hr)
CN (1) CN102056614A (hr)
AU (1) AU2009254262B2 (hr)
CA (1) CA2726872C (hr)
DK (1) DK2285393T3 (hr)
ES (1) ES2393239T3 (hr)
HR (1) HRP20120874T1 (hr)
IL (1) IL209714A (hr)
PL (1) PL2285393T3 (hr)
PT (1) PT2285393E (hr)
RU (1) RU2518738C2 (hr)
SI (1) SI2285393T1 (hr)
WO (1) WO2009146807A1 (hr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011082835A1 (en) * 2010-01-11 2011-07-14 Vitro-Bio Sarl New synergistic compositions for the treatment of topical viral infections
IT1402018B1 (it) * 2010-10-11 2013-08-28 Indena Spa Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
AU2013244472B9 (en) * 2012-04-03 2015-02-19 The Shizuoka Chamber Of Commerce And Industry Composition for improving resistance to environmental stress of plant and method for improving resistance to environmental stress of plant
JP6320842B2 (ja) * 2014-05-15 2018-05-09 株式会社シオンテック 抗菌性繊維の製造方法及び抗菌性繊維
CN114984010A (zh) * 2019-08-31 2022-09-02 广州自远生物科技有限公司 异喹啉类化合物制备抗猪呼吸与繁殖综合征病毒产品中的用途
JP7104926B1 (ja) * 2021-08-03 2022-07-22 宇航人ジャパン株式会社 ヘルパーt細胞増加剤およびヘルパーt細胞増加用の食品組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818533A (en) * 1985-07-09 1989-04-04 Vipont Pharmaceutical, Inc. Production of high purity alkaloids
RU2098111C1 (ru) 1994-03-30 1997-12-10 Научно-производственное объединение "Всероссийский научно-исследовательский институт лекарственных и ароматических растений" Способ получения противовирусного препарата "гипорамин"
US20020132021A1 (en) * 1997-04-30 2002-09-19 Ilya Raskin Elicited plant products
JP2000109428A (ja) * 1998-10-05 2000-04-18 Taisho Pharmaceut Co Ltd 咽頭粘膜用組成物
IL152827A0 (en) * 2000-05-18 2003-06-24 Herbal composition useful for treatment of oral cavity and a method for the local delivery thereof
ITMI20021691A1 (it) * 2002-07-30 2004-01-30 Indena Spa Estratti di echinacea angustifolia
RU2311192C2 (ru) * 2003-03-31 2007-11-27 Каунсил Оф Сайентифик Энд Индастриал Рисерч Способ получения антибактериальной и антиоксидантной фракции из семян облепихи (hippophae rhamnoides l.)
US20050031718A1 (en) * 2003-04-10 2005-02-10 Pharmanex, Llc Sea Buckthorn compositions and associated methods
ITMI20042414A1 (it) * 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
US7491414B2 (en) 2005-10-12 2009-02-17 Gaia Herbs, Inc. Anti-inflammatory substances extracted from Echinacea

Also Published As

Publication number Publication date
CA2726872C (en) 2017-05-02
RU2518738C2 (ru) 2014-06-10
AU2009254262A1 (en) 2009-12-10
JP2011521982A (ja) 2011-07-28
KR20110027671A (ko) 2011-03-16
US20110135769A1 (en) 2011-06-09
EP2285393B1 (en) 2012-08-15
CN102056614A (zh) 2011-05-11
AU2009254262B2 (en) 2014-02-13
PT2285393E (pt) 2012-11-29
WO2009146807A8 (en) 2010-02-04
PL2285393T3 (pl) 2013-01-31
IL209714A0 (en) 2011-02-28
DK2285393T3 (da) 2012-10-22
IL209714A (en) 2014-02-27
JP2016147914A (ja) 2016-08-18
JP5992171B2 (ja) 2016-09-14
WO2009146807A1 (en) 2009-12-10
ES2393239T3 (es) 2012-12-19
US9101604B2 (en) 2015-08-11
EP2285393A1 (en) 2011-02-23
SI2285393T1 (sl) 2012-12-31
RU2010153660A (ru) 2012-07-20
CA2726872A1 (en) 2009-12-10

Similar Documents

Publication Publication Date Title
HRP20120874T1 (hr) Pripravci za lijeäśenje poremeä†aja gornjeg dišnog trakta i sindroma influence
WO2014093127A3 (en) Method of administering nicotine, thc, tobacco, cannabidiol or base alkaloid and absorption conditioning unit
HRP20160327T1 (hr) Čvrsti dozirni oblici fentanila s poboljšanom bukalnom apsorpcijom
HRP20201386T1 (hr) Farmaceutska kompozicija, koja sadrži čestice vezivnog sredstva za fosfat
AR073604A1 (es) Granulado que contiene nicotina
IL191260A (en) Derivatives 4-alkyl-8-hydroxy-3,2-dihydro-pyrolo [2,3- c] quinoline, a process for preparing them and pharmacological formulations against bacteria and fungi containing them
NO336678B1 (no) Anvendelse av ekstraherte botaniske antocyanosider, sanguariner og keleritriner for fremstilling av sammensetninger til munnhygiene
AR060931A1 (es) Producto farmaceutico recubierto para la administracion intraoral de nicotina y su uso y elaboracion
AR083150A1 (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona
RS52777B (en) CURRENT RELEASE THERAPY SYSTEM FOR IMPROVED ORAL ABSORPTION 7 - [(E) -TERT-BUTYLOXYIMINOMETHYL] CAMPTOTECIN
ITMI20030195A1 (it) Formulazioni topiche contenenti principi attivi naturali adatte alla prevenzione e cura dei processi infiammatori delle mucose
WO2006100595A3 (en) Chewing gum compositions of varenicline
ATE459363T1 (de) Getrocknetes extrakt aus mit vaccinia-viren geimpfter, entzündeter kaninchenhaut und prozess zur herstellung
WO2020053662A3 (en) Non-aqueous solutions for oral dosage
Santos et al. Evaluation of mechanisms involved in the antinociception of the ethanol extract from the inner bark of Caesalpinia pyramidalis in mice
Mohanasundari et al. Modulating effect of Hypericum perforatum extract on astrocytes in MPTP induced Parkinson's disease in mice.
CN103275621B (zh) 中草药防虫抗菌地板蜡及其制备方法
Chakraborty et al. Phytochemical screening & in vivo fertility enhancing activity (aphrodisiac) of Abutilon indicum roots on male Wistar rats
Verma et al. Evaluation of synergistic analgesic activity of berberine and asiatic acid in mice
Fogha et al. Morinda lucida stem bark protects paracetamol induced liver damage
WO2011013992A3 (en) R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial
Newairy et al. The potential therapeutic effect of red clover’s extract against an induced molecular neurodegeneration in male rats
Saini et al. Role of Medicinal Plants and
WO2005099730A8 (en) Extracts of latex of calotropis procera and to a method of preparation thereof
ITMI20081029A1 (it) Composizioni per il trattamento delle affezioni delle prime vie respiratorie e delle sindromi influenzali